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Objective: Functional capacity is commonly impaired after critical 
illness. We sought to clarify the relationship between objective 
measures of physical activity, self-reported measures of health-
related quality of life, and clinician reported global functioning 
capacity (frailty) in such patients, as well as the impact of prior 
chronic disease status on these functional outcomes.
Design: Prospective outcome study of critical illness survivors.
Setting: Community-based follow-up.
Patients: Participants of the Musculoskeletal Ultrasound Study 
in Critical Care: Longitudinal Evaluation Study (NCT01106300), 
invasively ventilated for more than 48 hours and on the ICU 
greater than 7 days.
Interventions: None.
Measurements and Main Results: Physical activity levels (health-
related quality of life [36-item short-form health survey] and daily 
step counts [accelerometry]) were compared to norm-based or 
healthy control scores, respectively. Controls for frailty (Clinical 
Frailty Score) were non-morbid, age- and gender-matched to 
survivors. Ninety-one patients were recruited on ICU admission: 
41 were contacted for post-discharge assessment, and data 
were collected from 30 (14 female; mean age, 55.3 yr [95% CI, 
48.3–62.3]; mean post-discharge, 576 d [95% CI, 539–614]). 
Patients’ mean daily step count (5,803; 95% CI, 4,792–6,813) 
was lower than that in controls (11,735; 95% CI, 10,928–
12,542; p < 0.001), and lower in those with preexisting chronic 
disease than without (2,989 [95% CI, 776–5,201] vs 7,737 
[95% CI, 4,907–10,567]; p = 0.013). Physical activity measures 
(accelerometry, health-related quality of life, and frailty) demon-
strated good construct validity across all three tools. Step vari-
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ability (from sd) was highly correlated with daily steps (r2 = 0.67; 
p < 0.01) demonstrating a potential boundary constraint.
Conclusions: Subjective and objective measures of physical 
activity are all informative in ICU survivors. They are all reduced 
18 months post-discharge in ICU survivors, and worse in those 
with pre-admission chronic disease states. Investigating interven-
tions to improve functional capacity in ICU survivors will require 
stratification based on the presence of premorbidity. (Crit Care 
Med 2016; XX:00–00)
Key Words: critical illness; intensive care; motor activity; outcome 
assessment (health care); recovery of function; survivors
IntrODuCtIOn
Of the estimated 27 million ICU survivors alive today, over 
60% will have experienced sustained and significant impair-
ment of physical function (PF) after hospital discharge (1). 
However, the relationship between functional impairment and 
the presence of chronic disease prior to ICU admission is not 
well understood.
Such survivor disability has been assessed using objective 
(2, 3) and subjective (4) tools, with subjective questionnaire-
based self-reporting (2, 5, 6) being commonly used. Health-
related quality of life (HRQL) questionnaires have generally 
been employed as the default for long-term physical, psycho-
logical, and cognitive outcomes in survivors of critical illness. 
Although objective assessment with physical activity (PA) 
monitoring and compliance analysis (7) may define physical 
disability in greater detail, the validity of such objective mea-
sures, when compared to the subjective measures used in the 
post-critical care population, is poorly described.
Meanwhile, rehabilitation goals need to be individualized 
given the increasing variation in medical complexity exhibited 
by critical illness survivors (8). Indeed, the lack of benefit dem-
onstrated by some randomized controlled trials of rehabilita-
tion could partly reflect the failure to do so (9–12). The current 
assessment tools used to establish the effectiveness of reha-
bilitation strategies in ICU survivors may not offer sufficient 
granularity to detect the variability in functional outcome (2), 
requiring large numbers of patients to adequately power inter-
ventional clinical trials. Such interventions may be targeted at 
reducing post-ICU frailty (13, 14).
We thus aimed to explore the relationship between objective 
measures of PA, self-reported measures of physical HRQOL, 
and clinician-reported global functioning (frailty). In addi-
tion, we investigated the relationship between chronic disease 
status prior to critical illness and functional outcome.
MAtErIALS AnD MEtHODS
We studied patients recruited to the Musculoskeletal Ultra-
sound Study in Critical Care: Longitudinal Evaluation study 
(NCT01106300, www.clinicaltrials.gov: ethical approval: Uni-
versity College London Ethics Committee A), which assessed 
the early impact of critical illness on muscle mass (15). 
Enrolment and follow-up are shown in Figure S1 (Supplemen-
tal Digital Content 1, http://links.lww.com/CCM/B700).
In brief, patients were recruited within 24 hours of admis-
sion to a university hospital and a community hospital (August 
2009 to April 2011). All were anticipated to 1) be invasively 
ventilated for greater than or equal to 48 hours, 2) spend 
greater than or equal to 7 days in the ICU, and 3) survive ICU. 
Patients were subsequently excluded if these criteria were not 
met. Patients were also excluded if pregnant, a lower limb 
amputee, or suffering a primary neuromuscular pathology 
or active disseminated cancer. At enrolment, written assent 
was obtained from the next-of-kin, with retrospective patient 
consent obtained when possible. Chronic disease was defined 
by hospital and general practice coding for management of 
chronic disease, plus the Charlson Co-morbidity Index (16). 
A home visit 18 months post-ICU discharge was requested 
from patients, when HRQL and frailty were assessed and an 
accelerometer fitted. This time point was selected to maximize 
information about long-term outcomes within the constraints 
of limited available resources.
Measures of PA
Objective PA was recorded daily using a bi-axial accelerom-
eter armband (SenseWear; BodyMedia, Pittsburgh, PA), and 
measured over at least 5 days incorporating one weekend and 
four weekdays. A valid PA assessment was defined as 90% on-
body time per day for greater than or equal to 5 days (7), and 
data analyzed using SenseWear Professional software (version 
6.1). Daily step counts were adjusted for age and time post-
discharge, and compared with previously published controls 
(7). Patients were blinded to daily step count, such data only 
being accessible on data download. Daily step variability was 
taken as the sd of at least 5 days of step data.
Subjective HRQL was assessed using the 36-item short-
form health survey (SF-36) Questionnaire v 2.0 (UK version, 
licensed from QualityMetric, Lincoln, RI) (17), which com-
prises eight domain scales (Physical Function; Role-Physical; 
Bodily Pain; General Health; Vitality; Social Function; Role-
Emotional; Mental Health). Two component summary scores 
(Physical [PCS] and Mental [MCS]) are derived from the 
four physical health and mental health domains, respec-
tively. Inbuilt algorithms determine domain scores (from 0 
[least healthy] to 100 [most healthy]), which were compared 
to scores from a large published U.K. control cohort (18). 
Domain scores and component summary scores were also 
compared with norm-based control scores (mean, 50; sd, 10) 
provided by inbuilt algorithms (17). Comparison to popula-
tion norms is standard for ICU follow-up studies using SF-36 
scoring (2, 5, 6).
Clinical frailty was assessed during ICU survivor home visits 
using the Clinical Frailty Scale (CFS), a valid tool previously suc-
cessfully applied in the critically ill (4, 19). This is a short frailty 
scale focusing on levels of energy, activity, and exercise; impact 
of symptoms of medical problems on activities; level of physi-
cal and cognitive dependency inside and outside the home; and 
ability to cope with a minor illness (19), which correlates with 
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a longer 70-item assessment of frailty (20). Scores range from 
one (very fit) to nine (terminally ill) (Table S1, Supplemental 
Digital Content 1, http://links.lww.com/CCM/B700), and relate 
to other individuals within the same age range.
Study scores were adjusted for time post-ICU discharge. A 
group of non-morbid controls, age- and gender-matched to the 
ICU survivors were recruited from the community (n = 30), 
and their CFS scores assessed from observations on mobility 
and general lifestyle, using the same technique of passive par-
ticipant observation and during a similar period (30 min) as 
for the ICU survivors.
Statistical Analysis
General. Data were assessed for normality using D’Agostino 
and Pearson omnibus normality tests. Mean values were com-
pared using two-tailed unpaired t tests. Correlations between 
different measures of PA were determined by Spearman’s rank 
correlation coefficient analysis in order to assess construct 
validity. A post-hoc power calculation (G*Power 3.1 9.2, Kiel, 
Germany) was performed to determine whether sample sizes 
were large enough to show differences between patients with 
and without chronic disease. Statistical analysis was performed 
using Statistical Package for Social Sciences, version 22 (SPSS, 
Armonk, NY). Data are reported as mean (95% CI), except 
where only mean (sd) control values were available.
Effect Sizes/Sample Size Calculations. Projected PA vari-
ables for ICU survivors, and subcohorts with and without 
chronic disease, were derived from values reported in the lit-
erature, enabling effect and sample sizes for these three patient 
groupings (all survivors, those with chronic disease and those 
without) to be calculated for future interventional rehabilita-
tion trials using G*Power (3.1 9.2, Kiel, Germany):
1. Steps: Three levels of daily step count were selected as sta-
tistical targets for future rehabilitation studies: A “some-
what active” population mean (8,750 steps/d) for the whole 
ICU population (21, 22); the control level of steps (10,000 
steps/d) for ICU survivors without pre-morbid disease 
(21, 22); and a “low-active” mean (6,250 steps/d) for sur-
vivors with pre-existing chronic disease (21, 22) (Table S2, 
Supplemental Digital Content 1, http://links.lww.com/
CCM/B700).
2. Physical HRQL: Calculations were performed for nor-
malization of SF-36 PCS for patients without pre-morbid 
chronic disease and those from the whole survivor group 
(score of 50); and those in survivors with pre-morbid 
chronic disease for improvement to the mean level of PCS 
values in non-critically ill individuals with chronic disease 
(mild chronic obstructive pulmonary disease) (score of 42) 
(23). (Table S2, Supplemental Digital Content 1, http://
links.lww.com/CCM/B700).
3. Frailty: A CFS score of 3 indicates low PA in a non-frail pop-
ulation (projected level for those with pre-morbid chronic 
disease); a score of 2 indicates normal activity (projected 
level for those without pre-morbid chronic disease) (19) 
(Table S2, Supplemental Digital Content 1, http://links.lww.
com/CCM/B700).
rESuLtS
test Population
Of 91 patients recruited into the original study (15), 31 became 
ineligible either due to death or early discharge from ICU and 
four withdrew, leaving 56 patients discharged from hospital. 
Eighteen months post-ICU discharge (mean, 576 d [95% CI, 
539–614]), eight more had died, seven were lost to follow-up, six 
had withdrawn, three had significant morbidity, and two were 
non-responders. Thirty patients provided post-ICU discharge 
data (14 female; age, 55.3 yr [95% CI, 48.3–62.3]) (Fig. S1, 
Supplemental Digital Content 1, http://links.lww.com/CCM/
B700). Baseline details of those providing complete data 
(including accelerometry) (n = 27), plus the cohorts with 
(n = 11) and without (n = 16) chronic disease are shown in 
Table 1, and for those lost to follow-up (Table S3, Supplemen-
tal Digital Content 1, http://links.lww.com/CCM/B700).
Measures of PA and the Impact of Chronic Disease
Biaxial Accelerometer Data. Activity data were not collected 
from two immobile patients, and one patient was non-compliant; 
no remaining patients used walking aids. The use of activity 
monitors in this group of ICU survivors is well tolerated and 
resulting assessments are valid. ICU survivors demonstrated 
reduced daily step count compared with previously reported 
healthy controls (7) (5,803 [95% CI, 4,792–6,813] vs 11,735 
[95% CI, 10,928–12,542]; p < 0.001). However, previously 
healthy ICU survivors had a mean daily step count significantly 
greater than that of those who suffered preadmission comorbid-
ity (7,737 [95% CI, 4,907–10,567] vs 2,989 [95% CI, 776–5,201]; 
p = 0.013), but less than that of controls (7,737 [95% CI, 4,907–
10,567] vs 11,735 [95% CI, 10,928–12,542]; p = 0.014) (Fig. 1).
Step variability, assessed by sd, was highly correlated with 
daily steps (r2 = 0.67, p < 0.01) (Fig. 2) demonstrating a poten-
tial boundary constraint (Table S4, Supplemental Digital 
Content 1, http://links.lww.com/CCM/B700).
HRQL. ICU survivors had significantly worse PCS and 
PF compared with controls (mean ± sd: 41 ± 12 vs 50 ± 10; 
p < 0.001 and 52 ± 36 vs 88 ± 20; p < 0.001, respectively). Sig-
nificant differences were seen between previously healthy ICU 
survivors and those with chronic disease, in PCS (46.0 [95% 
CI, 39.9–52.0] vs 34.0 [95% CI, 28.0–40.0]; p = 0.007) and PF 
scores (68.4 [95% CI, 50.1–86.8] vs 29.1[95% CI, 12.4–45.7]; 
p = 0.003). Data on differences in HRQOL domain and com-
ponent summary scores for the various patient groups are 
summarized in Figure 3, with detailed comparison available 
in Table S4 (Supplemental Digital Content 1, http://links.lww.
com/CCM/B700).
Clinical Frailty. Median CFS score was higher in ICU sur-
vivors than sex- and age-matched controls (4.0; [interquartile 
range (IQR) = 3.0; upper quartile [Q
3
] = 5.0; lower quartile 
[Q
1
] = 2.0] vs 2.0 [IQR = 1.0; Q
3
 = 2.0; Q
1
 = 1.0]) indicating 
greater frailty. Differences were also seen between previously 
healthy and chronic disease cohorts (2.0 [IQR = 2.8; Q
3
 = 4.8; 
Q
1
 = 2.0] vs 5.0 [IQR 3.0; Q
3
 = 7.0; Q
1
 = 4.0]), respectively; 
the latter sub-cohort had a higher median CFS score than the 
matched controls 2.0 [IQR = 2.0; Q
3
 = 3.0; Q
1
 = 1.0].
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tAbLE 1. baseline Characteristics of Patients
Characteristic
Whole  
Cohort
Without Chronic  
Disease
With Chronic  
Disease p
n 27 16 11
Age (yr) 54 (46.6–61.6) 44.4 (35.8–53) 68.2 (59.1–77.4) < 0.001a
Male sex, n (%)b 13 (48.1) 6 (37.5) 7 (63.6) 0.181
Pre-ICU LOS (d)c 1 (1–4) 1 (1–4) 2 (1–3) 0.072
Ventilator daysc 7 (2–24) 7 (2–16) 7 (4–24) 0.426
ICU LOS (d)c 16 (7–73) 13.5 (7–34) 16 (10–73) 0.142
Hospital LOS (d)c 33 (15–141) 28 (15–67) 38 (17–141) 0.488
Acute Physiology and Chronic Health 
Evaluation score II
23.5 (21.5–25.5) 23.0 (20.3–25.7) 24.3 (20.8–27.7) 0.529
Simplified Acute Physiology Score II 44.8 (39.5–50.0) 46.1 (38.5–53.8) 42.8 (34.8–50.9) 0.601
Admission Sequential Organ Failure 
Assessment Score
8.8 (7.5–10.1) 9.1 (7.2–11.1) 8.3 (6.5–10.0) 0.515
Charlson Co Morbidity Indexc 0 (0–5) 0 (0–1)d 3 (0–5)e < 0.0001a
Admission RFCSA (mm
2) 430 (360–499) 450 (347–552) 400.7 (298–504) 0.631
Change in RFCSA over 10 d expressed as a 
percentage
17.9 (13.4–22.4) 16 (10.0–22.1) 21.2 (13.1–29.4) 0.265
Discharge home (%) 18 (66.7) 9 (56.3) 9 (81.8) 0.227
Admission diagnosis, n (%)
 Sepsis 13 (48.1) 7 (43.8) 6 (54.5)
 Trauma 6 (22.2) 6 (37.5) 0 (0.0)
 Intracranial bleeding 2 (7.4) 2 (12.5) 0 (0.0)
 Cardiogenic shock 6 (22.2) 1 (6.3) 5 (45.5)
Comorbidities, n (%)
 Chronic obstructive pulmonary disease 0 (0.0) 4 (36.3)
 Ischemic heart disease 0 (0.0) 4 (36.3)
 Hypertension 2 (12.5) 4 (36.3)
 Diabetes mellitus 1 (0.1) 1 (9.1)
 Hematological disease 0 (0.0) 1 (9.1)
 Obesity 0 (0.0) 1 (9.1)
 Chronic pancreatitis 0 (0.0) 1 (9.1)
 Renal impairment 0 (0.0) 4 (36.3)
 Crohn’s disease 0 (0.0) 1 (9.1)
 Thyroid disease 2 (12.5) 1 (9.1)
 Parkinson’s disease 0 (0.0) 1 (9.1)
LOS = length of stay, RFCSA = rectus femoris cross sectional area.
a p < 0.05.
Values	are	mean	with	(95%	CIs),	except	for	c indicating median with range. Student’s t test was used except for b chi-square and c Mann-Whitney U.
d Including one patient with non-insulin dependent diabetes mellitus taking metformin.
e Including one patient with severe Crohn’s disease (not scored by Charlson Comorbidity Index [16]), hypothyroidism, and hypertension.
ICU Survivors Providing Physical Activity Data (n = 27) and sub-cohorts with (n = 11) or without (n = 16) chronic disease.
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Construct Validity Across PF Measures
Construct validity, the degree to which a test measures what it 
claims to measure, is indicated by the Coefficient of Determi-
nation (r2) from regression between experimental and previ-
ously validated variables.
High correlations across PA measures were maintained 
when corrected for age and time post-discharge. (abbreviated 
construct validity is shown in Table 2) (full results in Table S5 
and Figs. S2 and S3, Supplemental Digital Content 1, http://
links.lww.com/CCM/B700).
PA measures demonstrated good construct validity across 
all three tools. Bedside physiology variables showed no rela-
tionships with these measures (Table 2).
Floor and Ceiling Effect
Ceiling and floor effects refer to levels either above or below 
which variables can no longer be differentiated. No floor or 
ceiling effects were seen with accelerometer use. In HRQL, a 
0% floor was seen across cohorts and domains, though 11.1% 
of previously healthy patients rated PF at maximal scores. CFS 
scoring demonstrated a floor effect of 0.07%, i.e., one patient 
in each sub-cohort was either very severely frail or terminally 
ill; and a ceiling effect of 0.04%, i.e., one patient was very active 
for the age group.
Statistical Calculations for Future trial Design
Estimated effect and sample sizes varied considerably 
(Table 3), likely secondary to the boundary constraint effect 
seen in patients with lower step counts (those with pre-morbid 
chronic disease).
DISCuSSIOn
In our study, three independent methods of assessment–
patient-reported HRQL, clinician-reported frailty score, and 
objective accelerometry–demonstrate impaired PA in ICU 
survivors, in agreement with published data (2, 24–29). How-
ever, we have shown that this impairment is not uniform, being 
greatest in those with pre-morbid chronic disease.
Our data show that accelerometry-derived data (daily step 
count) correlate well with other measures of physical inca-
pacity (physical aspects of HRQL and frailty score) and dem-
onstrate no floor or ceiling effects, unlike the SF-36 and CFS 
scores, confirming the validity of its use (Table 2) (Table S5 and 
Figs. S2 and S3, Supplemental Digital Content 1, http://links.
lww.com/CCM/B700). In addition, new insights are apparent 
from considering variation in daily PA. Thus, variation in daily 
step count was greatest in those most active, consistent with a 
boundary constraint effect: those with high exercise capacity 
can choose activity up to their maximal limit, while those least 
able to exercise are constrained to a narrow range of activity 
levels. The use of activity monitors–which are well tolerated 
and show good compliance in this patient group–may there-
fore add greater granularity to assessment of functional dis-
ability post-critical illness (Fig. 1).
Frailty is associated with greater risk of institutionalization, 
lower survival, and significantly lower HRQL in ICU survivors 
12 months post-ICU admission (4, 29). We identified frailty 
Figure 1. Daily steps for the cohort of ICU survivors providing complete 
data (including accelerometry) (n = 27) and subgroups of the previously 
healthy (n = 16) and those with pre-existing chronic disease (n = 11) vs 
controls. *p < 0.05 for unpaired two-tailed Student t test. #p < 0.05 for 
Mann-Whitney U test as data was non-normally distributed.
Figure 2. Linear regression between mean daily steps and sd (as a 
measure of step variability) in the cohort of ICU survivors providing 
complete data (including accelerometry) (n = 27).
Figure 3. Health-related quality of life (from Medical Outcomes Study 
Short Form 36 Questionnaire Domain Scores) for population controls, 
critical illness survivor cohort providing complete data (including 
accelerometry) (n = 27) and sub-cohorts with (n = 11) or without 
(n = 16) pre-morbid chronic disease. BP = bodily pain, GH = general 
health, MH = mental health, PF = physical function, RE = role emotional, 
RP = role physical, SF = social functioning, VT = vitality. *U.K. population 
controls (n = 8,889) (18).
Copyright © 2016 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved.
McNelly et al
6 www.ccmjournal.org	 XXX	2016	•	Volume	XX	•	Number	XXX
in 37% of ICU survivors, compared with the 32% prevalence 
on ICU admission recently reported (4). Our data suggest that 
frailty correlates strongly with PF SF-36 scores and lower daily 
step counts, and may be a useful alternative outcome measure, 
especially given the potential of translating multimodal com-
munity interventions from the ageing literature (30, 31).
Implications for Prospective Interventional trials
ICU survivors with and without chronic disease appear to behave 
as separate cohorts: by 18 months, the latter have daily step 
counts only one-third lower than those of healthy controls, with 
substantially greater HRQL and significantly less frailty than the 
cohort with pre-morbid disease, reflecting a trajectory of recov-
ery. In conjunction with a recent secondary analysis of a previ-
ously published exercise intervention study (32), this finding 
strengthens the argument that successful long-term interventions 
in ICU survivors will require stratification based on the presence 
of pre-morbidity, i.e., a personalized rehabilitation approach.
All three tools show good construct validity across assess-
ments with little evidence of floor/ceiling effects suggesting 
that the assessment method should be determined by the pur-
pose of the intervention—e.g., daily step count for an exercise 
only-intervention, and HRQL or frailty scales for multimodal 
interventions. Importantly, combined use of these outcome 
measures may elucidate useful components of multimodal 
interventions, especially in the setting of negative or neutral 
trial results (9–12).
The effect size calculations reveal potential difficulties in trial 
design, e.g., achieving the effect size necessary for CFS use would 
likely require a major interdisciplinary intervention (14). When 
considering physical rehabilitation, stratification of cohorts by 
presence or absence of chronic disease can reduce numbers sig-
nificantly. However, if a mixed cohort is used, the presence of 
high numbers of pre-morbidly healthy patients may result in a 
high proportion of “false negative” results. This potential skew 
is likely a result of the boundary constraint demonstrated in 
tAbLE 2. Values of Clinical Frailty Scale Scores and Variables of Daily Step Count versus 
Measures of Physical Activity and bedside Physiology: Abbreviated Construct Validity Data
Comparator
Clinical Frailty  
Scale
Daily Step  
Count
Variation in Daily  
Step Count
r2 p r2 p r2 p
SF-36 Physical Component Summary score 0.56 < 0.01 0.25 < 0.01 0.09 NS
SF-36 Mental Component Summary score 0.21 < 0.05 0.03 NS 0.03 NS
SF-36 Physical Function score 0.67 < 0.01 0.51 < 0.01 0.24 < 0.01
Daily step count 0.55 < 0.01 — — 0.67 < 0.01
Variation in daily step count 0.32 < 0.01 0.67 < 0.01 — —
Acute Physiology and Chronic Health Evaluation II 0.04 NS 0.06 NS 0.07 NS
Simplified Acute Physiology Score II 0.002 NS 0.02 NS 0.01 NS
Sequential Organ Failure Assessment 0.06 NS 0.01 NS 0.001 NS
r2  = coefficient of determination, SF-36 = 36-item short-form health survey, NS = p > 0.05.
Dashes indicate where the same parameter for r2  values is in both columns.
tAbLE 3. Estimated Effect and Sample (n) Sizes for Future Interventional Clinical trials in 
ICu Survivors
Physical Activity Variable
Effect or  
Sample Size
Whole 
Cohort
Without Chronic 
Disease
With Chronic  
Disease
Daily step count Effect size 0.29 0.22 0.5
n 62 103 24
36-item short-form health survey 
Physical Component Summary 
score
Effect size 0.37 0.18 0.31
n 38 162 54
Clinical Frailty Scale score Effect size 0.42 0.29 0.43
n 30 60 30
n = sample size.
Whole ICU survivor cohort, those with and without chronic disease.
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this study: significant variation in step count in survivors with-
out pre-morbid disease necessitates larger sample sizes.
The shaded areas in Figure 4 provide a hypothetical 
representation of the potential for rehabilitation in these 
two cohorts of ICU survivors: it shows the “rehabilitation 
gap” between their observed PA levels 18 months post-
ICU admission, and what might be achieved with suitable 
intervention.
Post-ICU HRQL differs with the presence or absence of pre-
admission chronic disease. The nature of rehabilitation efforts 
required, and the maximal gain which they might deliver, is 
thus likely to vary between such groups; ICU-acquired PA 
deficits may also contribute to heterogeneity in response to 
rehabilitation. This is not clear when only the average impact is 
considered. The differences in scores between survivors with-
out pre-morbidity and the whole ICU survivor group suggest 
that scores from previously healthy survivors could introduce 
type II errors, potentially contributing to the lack of positive 
reports from intervention trials (9–12). In addition, psychoso-
cial deficits (including depression and posttraumatic stress dis-
order), which are known to negatively impact PA capabilities, 
have been reported in ICU survivors (33) and may contribute 
to their physical dysfunction.
Limitations
Primary prevention of muscle wasting (34) and proac-
tive rehabilitation (35) mandate enrolling patients at ICU 
admission for trials (9). However, high dropout rates are well 
described in the literature, primarily due to mortality, either 
in hospital or during the first few months in the community 
(9, 12, 36–39). From our data, an 18-month follow-up study 
on 100 survivors would require recruiting 303 patients on 
admission to ICU. The use of inner city tertiary care loca-
tions as study sites increases the risk of patients being lost to 
follow-up due to the widespread locations of patients, and 
the lack of a fixed address for a proportion of the target pop-
ulation. In this pilot study, there were insufficient resources 
for follow-up beyond 100 miles, and this contributed to 
the numbers lost. Age-adjustment of results overcame any 
potential influence from mean age differences in those fol-
lowed up versus not followed up. Approaches to enable all 
measurements from each participant to be used, regardless 
of time of drop-out (40), may be worth investigating for 
future studies.
The small sample size, preventing stratification by diag-
nostic category (15) and extrapolation to specific patient sub-
groups, may impact generalizability. That said, ICU-induced 
muscle loss and subsequent physical debility appear to relate 
to the state of critical illness per se, rather than being linked 
to a specific diagnosis (15). Twenty-seven survivors con-
tributed full data, a similar sample size to other studies of 
PA in ICU survivors and individuals with chronic disease 
(7, 28, 41). Rates of attrition secondary to mortality and 
loss to follow-up were comparable to a high-quality pub-
lished 1-year outcome study (28), highlighting the difficulty 
of research in this population. Further, a post-hoc power 
calculation (Table S6, Supplemental Digital Content 1, 
http://links.lww.com/CCM/B700) suggests that sufficient 
numbers of participants were studied to detect a between-
groups difference using PA monitoring or the PCS of the SF-36 
questionnaire. This is a further demonstration of the poten-
tially powerful effect of stratification of outcome studies (32).
Accelerometers may overestimate step count compared with 
pedometer-based values (42), though the strong correlations 
observed between objective and subjective measures 
suggest that this is of minimal impact.
COnCLuSIOnS
Activity monitoring appears well tolerated by ICU 
survivors, with a high level of compliance. Both 
subjective and objective measures suggest that PA 
levels are reduced 18 months post-discharge in ICU 
survivors, being worst in those with pre-admission 
chronic disease states. This suggests that rehabilita-
tion strategies and targets may need to differ for indi-
viduals with or without pre-morbid disease.
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Figure 4. Schematic projecting health-related quality of life surplus, deficit and possible 
rehabilitation target in critical illness survivors (n = 27) stratified by presence of chronic 
disease. BP = bodily pain, GH = general health, HRQL = Health-related quality of life, 
MH = mental health, MH = mental health, PF = physical function, RE = role emotional, 
RP = role physical, SF = social functioning, VT = vitality. *U.K. population controls 
(n = 8,889) (18).
Copyright © 2016 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved.
McNelly et al
8 www.ccmjournal.org	 XXX	2016	•	Volume	XX	•	Number	XXX
rEFErEnCES
 1. Adhikari NK, Fowler RA, Bhagwanjee S, et al: Critical care and the 
global burden of critical illness in adults. Lancet 2010; 376:1339–
1346
 2. Herridge MS, Tansey CM, Matté A, et al; Canadian Critical Care Trials 
Group: Functional disability 5 years after acute respiratory distress 
syndrome. N Engl J Med 2011; 364:1293–1304
 3. Denehy L, Nordon-Craft A, Edbrooke L, et al: Outcome measures 
report different aspects of patient function three months following 
critical care. Intensive Care Med 2014; 40:1862–1869
 4. Bagshaw SM, Stelfox HT, McDermid RC, et al: Association between 
frailty and short- and long-term outcomes among critically ill patients: 
A multicentre prospective cohort study. CMAJ 2014; 186:E95–102
 5. Chelluri L, Im KA, Belle SH, et al: Long-term mortality and quality 
of life after prolonged mechanical ventilation. Crit Care Med 2004; 
32:61–69
 6. Khouli H, Astua A, Dombrowski W, et al: Changes in health-related 
quality of life and factors predicting long-term outcomes in older adults 
admitted to intensive care units. Crit Care Med 2011; 39:731–737
 7. Shrikrishna D, Patel M, Tanner RJ, et al: Quadriceps wasting and 
physical inactivity in patients with COPD. Eur Respir J 2012; 
40:1115–1122
 8. Iwashyna TJ: Trajectories of recovery and dysfunction after acute ill-
ness, with implications for clinical trial design. Am J Respir Crit Care 
Med 2012; 186:302–304
 9. Denehy L, Skinner EH, Edbrooke L, et al: Exercise rehabilitation 
for patients with critical illness: A randomized controlled trial with 
12 months of follow-up. Crit Care 2013; 17:R156
 10. Cuthbertson BH, Rattray J, Campbell MK, et al; PRaCTICaL Study 
Group: The PRaCTICaL study of nurse led, intensive care follow-up 
programmes for improving long term outcomes from critical illness: 
A pragmatic randomised controlled trial. BMJ 2009; 339:b3723
	11.	Walsh	TS,	Salisbury	LG,	Merriweather	JL,	et	al;	RECOVER	Investiga-
tors: Increased Hospital-Based Physical Rehabilitation and Informa-
tion	Provision	After	 Intensive	Care	Unit	Discharge:	The	RECOVER	
Randomized Clinical Trial. JAMA Intern Med 2015; 175:901–910
 12. Elliott D, McKinley S, Alison J, et al: Health-related quality of life and 
physical recovery after a critical illness: A multi-centre randomised 
controlled trial of a home-based physical rehabilitation program. Crit 
Care 2011; 15:R142
 13. Fairhall N, Sherrington C, Lord SR, et al: Effect of a multifactorial, 
interdisciplinary intervention on risk factors for falls and fall rate in 
frail older people: A randomised controlled trial. Age Ageing 2014; 
43:616–622
 14. Cameron ID, Fairhall N, Langron C, et al: A multifactorial interdisci-
plinary intervention reduces frailty in older people: Randomized trial. 
BMC Med 2013; 11:65
 15. Puthucheary ZA, Rawal J, McPhail M, et al: Acute skeletal muscle 
wasting in critical illness. JAMA 2013; 310:1591–1600
 16. Charlson ME, Pompei P, Ales KL, et al: A new method of classifying 
prognostic comorbidity in longitudinal studies: Development and vali-
dation. J Chronic Dis 1987; 40:373–383
 17. Ware JE Jr, Sherbourne CD: The MOS 36-item short-form health sur-
vey (SF-36). I. Conceptual framework and item selection. Med Care 
1992; 30:473–483
 18. Jenkinson C, Stewart-Brown S, Petersen S, et al: Assessment of the 
SF-36 version 2 in the United Kingdom. J Epidemiol Community 
Health 1999; 53:46–50
 19. McDermid RC, Stelfox HT, Bagshaw SM: Frailty in the critically ill: A 
novel concept. Crit Care 2011; 15:301
 20. Rockwood K, Andrew M, Mitnitski A: A comparison of two approaches 
to measuring frailty in elderly people. J Gerontol A Biol Sci Med Sci 
2007; 62:738–743
 21. Tudor-Locke C, Hatano Y, Pangrazi RP, et al: Revisiting “how many 
steps are enough?”. Med Sci Sports Exerc 2008; 40:S537–S543
 22. Tudor-Locke C, Bassett DR Jr: How many steps/day are enough? 
Preliminary pedometer indices for public health. Sports Med 2004; 
34:1–8
 23. Ståhl E, Lindberg A, Jansson SA, et al: Health-related quality of life is 
related to COPD disease severity. Health Qual Life Outcomes 2005; 
3:56
 24. Herridge MS, Cheung AM, Tansey CM, et al; Canadian Critical Care 
Trials Group: One-year outcomes in survivors of the acute respiratory 
distress syndrome. N Engl J Med 2003; 348:683–693
 25. Needham DM, Dowdy DW, Mendez-Tellez PA, et al: Studying out-
comes of intensive care unit survivors: Measuring exposures and out-
comes. Intensive Care Med 2005; 31:1153–1160
 26. Jackson JC, Pandharipande PP, Girard TD, et al; Bringing to light the 
Risk Factors And Incidence of Neuropsychological dysfunction in ICU 
survivors (BRAIN-ICU) study investigators: Depression, post-trau-
matic stress disorder, and functional disability in survivors of critical 
illness in the BRAIN-ICU study: A longitudinal cohort study. Lancet 
Respir Med 2014; 2:369–379
 27. Prescott HC, Iwashyna TJ: Somatic symptoms in survivors of critical 
illness. Lancet Respir Med 2014; 2:341–343
 28. Denehy L, Berney S, Whitburn L, et al: Quantifying physical activ-
ity levels of survivors of intensive care: A prospective observational 
study. Phys Ther 2012; 92:1507–1517
 29. Bagshaw SM, Stelfox HT, Johnson JA, et al: Long-term association 
between frailty and health-related quality of life among survivors of 
critical illness: A prospective multicenter cohort study. Crit Care Med 
2015; 43:973–982
 30. Bagshaw SM, McDermid RC: The role of frailty in outcomes from criti-
cal illness. Curr Opin Crit Care 2013; 19:496–503
 31. McDermid RC, Bagshaw SM: Scratching the surface: The burden of 
frailty in critical care. Intensive Care Med 2014; 40:740–742
 32. Puthucheary ZA, Denehy L: Exercise Interventions in Critical Illness 
Survivors: Understanding Inclusion and Stratification Criteria. Am J 
Respir Crit Care Med 2015; 191:1464–1467
 33. Jackson JC, Hart RP, Gordon SM, et al: Post-traumatic stress disor-
der and post-traumatic stress symptoms following critical illness in 
medical intensive care unit patients: Assessing the magnitude of the 
problem. Crit Care 2007; 11:R27
 34. Puthucheary Z, Harridge S, Hart N: Skeletal muscle dysfunction in 
critical care: Wasting, weakness, and rehabilitation strategies. Crit 
Care Med 2010; 38:S676–S682
 35. Needham DM, Korupolu R, Zanni JM, et al: Early physical medicine 
and rehabilitation for patients with acute respiratory failure: A quality 
improvement project. Arch Phys Med Rehabil 2010; 91:536–542
 36. Mikkelsen ME, Christie JD, Lanken PN, et al: The adult respiratory 
distress syndrome cognitive outcomes study: long-term neuropsycho-
logical function in survivors of acute lung injury. Am J Respir Crit Care 
Med 2012; 185:1307–1315
 37. Herridge M, Cox C: Linking ICU practice to long-term outcome: Fos-
tering a longitudinal vision for ICU-acquired morbidity. Am J Respir 
Crit Care Med 2012; 186:299–300
 38. Harhay MO, Wagner J, Ratcliffe SJ, et al: Outcomes and statistical 
power in adult critical care randomized trials. Am J Respir Crit Care 
Med 2014; 189:1469–1478
 39. Lone NI, Walsh TS: Impact of intensive care unit organ failures on 
mortality during the five years after a critical illness. Am J Respir Crit 
Care Med 2012; 186:640–647
 40. Hofhuis JG, van Stel HF, Schrijvers AJ, et al: ICU survivors show no 
decline in health-related quality of life after 5 years. Intensive Care 
Med 2015; 41:495–504
 41. Langer D, Gosselink R, Pitta F, et al: Physical activity in daily life 1 year 
after lung transplantation. J Heart Lung Transplant 2009; 28:572–578
 42. Tudor-Locke C, Johnson WD, Katzmarzyk PT: Accelerometer-deter-
mined steps per day in US adults. Med Sci Sports Exerc 2009; 
41:1384–1391
